Figure 1.
Disease-related indicators before and after neoadjuvant chemotherapy for colorectal cancer. (A) Hematoxylin-eosin (HE) staining showing the tumor-stroma ratio before and after neoadjuvant chemotherapy. Immunohistochemical staining of GALC (B), Ki67 (C), p53 (D), and E-cadherin (E) was performed to explore the relationship between these markers and prognosis. p < 0.05 was considered statistically significant.